These responses to PBM treatments contribute to the immediate resilience to additional stressors (like oncotherapy or hyperglycemia), while the coordinated signaling among the redox–NFκB–TGF-β pathways result in a longer-term response that drives the resolution of the inflammatory microenvironment, culminating in tissue healing and regeneration. Here, TGFB1 is linked to Hyperglycemia.